HMMR and breast cancer: In various carcinomas (e.g., colorectal cancer [83], pancreatic ductal adenocarcinoma (PDA) [84], breast cancer [85], and multiple myeloma [86]), RHAMM is overexpressed and commonly associated with poor prognosis [87, 88].